Medivation Announces Participation at Upcoming Investor Conference

Medivation Announces Participation at Upcoming Investor Conference 
SAN FRANCISCO, CA -- (Marketwire) -- 02/06/13 --  Medivation, Inc.
(NASDAQ: MDVN) today announced that it will present at the following
conference: 


 
--  Patrick Machado, chief business and financial officer, will present at
    the Leerink Swann Global Healthcare Conference on February 13 at
    8:30am ET in New York, NY.

  
About Medivation 
Medivation, Inc. is a biopharmaceutical company focused on the rapid
development of novel therapies to treat serious diseases for which
there are limited treatment options. Medivation aims to transform the
treatment of these diseases and offer hope to critically ill patients
and their families. For more information, please visit us at
www.medivation.com. 
Contacts:
Patrick Machado 
Chief Business & Financial Officer
(415) 829-4101 
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900 
 
 
Press spacebar to pause and continue. Press esc to stop.